Christopher O. Petersen, Esq. c/o Columbia Management Investment Advisers, LLC 290 Congress Street Boston, Massachusetts 02110 |
Ryan C. Larrenaga, Esq. c/o Columbia Management Investment Advisers, LLC 290 Congress Street Boston, Massachusetts 02110 |
NYSE: STK |
3
| |
3 | |
4 | |
8 | |
11 | |
12 | |
13
| |
14 | |
15
| |
16 | |
16 | |
16 | |
17 | |
23 | |
25 | |
26 | |
26 | |
27 | |
28
| |
28 | |
29 | |
31 | |
33
| |
35 | |
35 | |
35 | |
35 | |
36 | |
36 | |
37 |
Stockholder Transaction Expenses | |
Sales Load(a) |
1.00 % |
Offering Expenses |
None (b) |
Dividend Investment Plan and Stock Repurchase Program Fees |
None
(c) |
Annual Expenses (as a percentage of net assets
attributable to Common Shares) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
Management fees(d) |
|
|
|
|
|
|
|
1.06 % |
|
|
Other expenses |
|
|
|
|
|
|
|
0.07 % |
|
|
Acquired fund fees and expenses |
|
|
|
|
|
|
|
0.00 % |
|
|
Total Annual Expenses(e)
|
|
|
|
|
|
|
|
1.13 % |
|
|
|
1 year |
3 years |
5 years |
10 years |
Common Shares |
$12 |
$36 |
$62 |
$137 |
Year ended December 31, |
2023 |
2022 |
2021 |
Per share data |
|
|
|
Net asset value, beginning of period |
$22.63 |
$35.42 |
$27.86 |
Income from investment operations: |
|
|
|
Net investment income (loss) |
(0.05 ) |
(0.08 ) |
(0.06 ) |
Net realized and unrealized gain (loss) |
8.58 |
(9.78 ) |
10.76 |
Total from investment operations |
8.53 |
(9.86 ) |
10.70 |
Less distributions to Stockholders from: |
|
|
|
Net investment income |
— |
— |
— |
Net realized gains |
(2.12 ) |
(2.93 ) |
(3.14 ) |
Total distributions to Stockholders |
(2.12 ) |
(2.93 ) |
(3.14 ) |
(Dilution) Anti-dilution in net asset value from share purchases (via dividend
reinvestment program)(a) |
0.01 |
(0.00 )(b) |
— |
Anti-dilution in net asset value from share buy-backs (via stock repurchase
program)(a) |
— |
— |
— |
Net asset value, end of period |
$29.05 |
$22.63 |
$35.42 |
Market price, end of period |
$31.60 |
$23.23 |
$37.01 |
Total return |
|
|
|
Based upon net asset value |
38.89 % |
(28.74 %) |
39.38 % |
Based upon market price |
47.19 % |
(29.99 %) |
48.96 % |
Ratios to average net assets |
|
|
|
Total gross expenses(c) |
1.13 % |
1.13 % |
1.13 % |
Net investment income (loss) |
(0.19 %) |
(0.29 %) |
(0.18 %) |
Supplemental data |
|
|
|
Net assets, end of period (in thousands): |
$478,924 |
$366,036 |
$564,220 |
Portfolio turnover |
25 % |
9 % |
27 % |
2020 |
2019 |
2018 |
2017 |
2016 |
2015 |
2014 |
|
|
|
|
|
|
|
$23.43 |
$16.96 |
$20.83 |
$17.78 |
$17.29 |
$17.69 |
$16.18 |
|
|
|
|
|
|
|
0.11 |
(0.02 ) |
(0.01 ) |
(0.06 ) |
(0.05 ) |
(0.04 ) |
(0.07 ) |
6.17 |
8.34 |
(1.36 ) |
5.74 |
2.39 |
1.49 |
3.43 |
6.28 |
8.32 |
(1.37 ) |
5.68 |
2.34 |
1.45 |
3.36 |
|
|
|
|
|
|
|
(0.11 ) |
— |
— |
— |
— |
— |
— |
(1.74 ) |
(1.85 ) |
(2.50 ) |
(2.63 ) |
(1.85 ) |
(1.85 ) |
(1.85 ) |
(1.85 ) |
(1.85 ) |
(2.50 ) |
(2.63 ) |
(1.85 ) |
(1.85 ) |
(1.85 ) |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
$27.86 |
$23.43 |
$16.96 |
$20.83 |
$17.78 |
$17.29 |
$17.69 |
$27.24 |
$23.55 |
$16.81 |
$22.25 |
$18.74 |
$17.93 |
$18.93 |
|
|
|
|
|
|
|
29.17 % |
51.04 % |
(7.77 %) |
32.72 % |
15.29 % |
8.40 % |
22.32 % |
25.65 % |
53.17 % |
(14.42 %) |
34.51 % |
17.18 % |
5.05 % |
47.17 % |
|
|
|
|
|
|
|
1.15 % |
1.15 % |
1.15 % |
1.16 % |
1.17 % |
1.17 % |
1.17 % |
0.50 % |
(0.08 %) |
(0.05 %) |
(0.28 %) |
(0.33 %) |
(0.24 %) |
(0.41 %) |
|
|
|
|
|
|
|
$443,114 |
$372,063 |
$265,315 |
$320,472 |
$273,226 |
$265,426 |
$271,300 |
32 % |
43 % |
34 % |
47 % |
61 % |
61 % |
60 % |
Title of Class |
Amount Authorized |
Amount Held by Fund or for
its Account |
Amount Outstanding
Exclusive of Amount
Held by Fund |
Common Stock, $0.01 par value per share |
1,000,000,000 shares |
0 shares |
16,579,622 shares |
|
Market Price ($) |
Corresponding NAV ($) |
Corresponding (Discount)/Premium to NAV (%) | |||
|
High |
Low |
High |
Low |
High |
Low |
2022 |
|
|
|
|
|
|
1st Quarter |
37.50 |
28.28 |
35.64 |
28.72 |
5.22 |
(1.53) |
2nd Quarter |
32.11 |
24.47 |
32.13 |
24.64 |
(0.06) |
(0.69) |
3rd Quarter |
32.24 |
23.19 |
28.62 |
22.78 |
12.65 |
1.80 |
4th Quarter |
27.69 |
22.48 |
25.84 |
21.98 |
7.16 |
2.27 |
2023 |
|
|
|
|
|
|
1st Quarter |
28.08 |
22.73 |
26.34 |
22.48 |
6.61 |
1.11 |
2nd Quarter |
31.35 |
26.23 |
27.65 |
24.66 |
13.38 |
6.37 |
3rd Quarter |
31.04 |
26.75 |
28.99 |
26.05 |
7.07 |
2.69 |
4th Quarter |
31.91 |
25.18 |
29.26 |
24.88 |
9.06 |
1.21 |
2024 |
|
|
|
|
|
|
1st Quarter |
34.05 |
29.37 |
30.72 |
27.81 |
10.84 |
5.61 |
When the VXN Index is: |
Aggregate Notional Amount of Written Call Options as a Percentage of the Fund’s
Holdings in Common Stocks |
17 or less |
25% |
Greater than 17, but less than
18 |
Increase up to 50% |
At least 18, but less than 33 |
50% |
At least 33, but less than 34 |
Increase up to 90% |
At least 34, but less than 55 |
90% |
At 55 or greater |
0% to 90% |
Portfolio Management |
Role with Fund |
Managed Fund Since |
Paul Wick |
Lead Portfolio Manager |
2009 |
Braj Agrawal |
Portfolio Manager |
2010 |
Christopher Boova |
Portfolio Manager |
2016 |
Jeetil Patel |
Technology Team Member |
2015 |
Vimal Patel |
Technology Team Member |
2018 |
Shekhar Pramanick |
Technology Team Member |
2018 |
SAIPRIMER..................................................................................................................................................
|
2 |
ABOUTTHEFUND.......................................................................................................................................... |
5 |
ADDITIONALINVESTMENTPOLICIES.............................................................................................................. |
6 |
ABOUTFUNDINVESTMENTS.......................................................................................................................... |
9 |
Types of
Investments................................................................................................................................. |
9 |
Information Regarding
Risks....................................................................................................................... |
45 |
Lending of Portfolio
Securities..................................................................................................................... |
77 |
Interfund
Lending....................................................................................................................................... |
77 |
INVESTMENTMANAGEMENTANDOTHERSERVICES...................................................................................... |
79 |
The Investment
Manager............................................................................................................................ |
79 |
Potential Conflicts of
Interest...................................................................................................................... |
81 |
Structure of
Compensation......................................................................................................................... |
83 |
The
Administrator....................................................................................................................................... |
84 |
Other Services
Provided............................................................................................................................. |
84 |
Other Roles and Relationships of Ameriprise Financial and Its Affiliates —
Certain Conflicts of Interest........... |
84 |
Codes of
Ethics.......................................................................................................................................... |
89 |
Proxy Voting Policies and
Procedures........................................................................................................... |
89 |
FUNDGOVERNANCE......................................................................................................................................
|
91 |
Board of Directors and
Officers................................................................................................................... |
91 |
Compensation............................................................................................................................................
|
101
|
BROKERAGEALLOCATIONANDRELATEDPRACTICES..................................................................................... |
103
|
General Brokerage Policy, Brokerage Transactions and Broker
Selection......................................................... |
103
|
Brokerage
Commissions............................................................................................................................. |
106
|
Directed
Brokerage..................................................................................................................................... |
107
|
Securities of Regular
Broker-Dealers............................................................................................................ |
107
|
TAXATION...................................................................................................................................................... |
108
|
CONTROLPERSONSANDPRINCIPALHOLDERSOFSECURITIES...................................................................... |
120
|
INFORMATIONREGARDINGPENDINGANDSETTLEDLEGALPROCEEDINGS..................................................... |
121
|
OtherInformation....................................................................................................................................
|
122
|
Certain Provisions of the Fund’s Charter and
Bylaws.................................................................................... |
122
|
ReportofIndependentRegisteredPublicAccountingFirmonFinancialStatementSchedule.. |
125
|
IncorporationbyReference................................................................................................................... |
126
|
APPENDIXA—DESCRIPTIONOFCREDITRATINGS........................................................................................ |
A-1 |
APPENDIXB—CORPORATEGOVERNANCEGUIDELINES................................................................................ |
B-1 |
2
| |
5 | |
6
| |
9 | |
9 | |
45 | |
77 | |
77 | |
79
| |
79 | |
81 | |
83 | |
84 | |
84 | |
84 | |
89 | |
89 | |
91 | |
91 | |
101 | |
103
| |
103 | |
106 | |
107 | |
107 | |
108 | |
120
| |
121 | |
122
| |
122 | |
125
| |
126 | |
A-1 | |
B-1 |
1933 Act |
Securities Act of 1933, as amended |
1934 Act |
Securities Exchange Act of 1934, as amended |
1940 Act |
Investment Company Act of 1940, as amended |
Ameriprise Financial |
Ameriprise Financial, Inc. |
Board |
The Fund’s Board of Directors |
Business Day |
Any day on which the NYSE is open for business. A business day typically ends at the close of regular trading on the NYSE, usually at 4:00 p.m. Eastern time. If the NYSE is scheduled to close early, the business day will be considered to end as of the time of the NYSE’s scheduled close.
The Fund will not treat an intraday unscheduled disruption in NYSE
trading or an intraday unscheduled closing as a close of regular trading
on the NYSE for these purposes and will price its shares as of the
regularly scheduled closing time for that day (typically, 4:00 p.m.
Eastern time). Notwithstanding the foregoing, the NAV of Fund
shares may be determined at such other time or times (in addition
to or in lieu of the time set forth above) as the Fund’s
Board may approve or ratify. On holidays and other days when the
NYSE is closed, the Fund's NAV is not calculated and the Fund does
not accept buy or sell orders. However, the value of the Fund's
assets may still be affected on such days to the extent that the
Fund holds foreign securities that trade on days that foreign
securities markets are open. |
CEA |
Commodity Exchange Act |
CFTC |
The United States Commodity Futures Trading Commission |
Code |
Internal Revenue Code of 1986, as amended |
Codes of Ethics |
The codes of ethics adopted by the Fund, Columbia Management Investment Advisers, LLC (the Investment Manager) and/or any sub- adviser, as applicable, pursuant to Rule 17j-1 under the 1940 Act |
Columbia Funds or Columbia Funds Complex |
The fund complex, including the Fund, that is comprised of the registered
investment companies, including traditional mutual funds, closed-end
funds, and ETFs, advised by the Investment Manager or its
affiliates |
Columbia Management |
Columbia Management Investment Advisers, LLC |
Columbia Threadneedle Investments |
The global brand name of the Columbia and Threadneedle group of companies |
Common Shares |
Shares of the Fund’s common stock |
Custodian |
JPMorgan Chase Bank, N.A. |
DBRS |
Morningstar DBRS |
Director(s) |
One or more of the Board’s Directors |
Distributor |
ALPS Distributors, Inc. is the Distributor of Common Shares issued by the
Fund solely in connection with the Fund's at-the-market offering.
|
FDIC |
Federal Deposit Insurance Corporation |
FHLMC |
The Federal Home Loan Mortgage Corporation |
Fitch |
Fitch Ratings, Inc. |
FNMA |
Federal National Mortgage Association |
GICS |
The Global Industry Classification Standard
(GICS®). GICS was developed
by and/or is the exclusive property of MSCI, Inc. (MSCI®) and S&P Global
Market Intelligence Inc. (S&P Global Market Intelligence). GICS is a
service mark of MSCI and S&P Global Market Intelligence and has
been licensed for use by the Investment Manager. Neither GICS,
MSCI, nor S&P Global Market Intelligence are affiliated with
the Fund, the Investment Manager or any Columbia
entity. |
GNMA |
Government National Mortgage Association |
Independent Directors |
The Directors of the Board who are not “interested persons” (as defined
in the 1940 Act) of the Fund |
Interested Director |
A Director of the Board who is currently deemed to be an “interested
person” (as defined in the 1940 Act) of the Fund |
Investment Manager |
Columbia Management Investment Advisers, LLC |
IRS |
United States Internal Revenue Service |
JPMorgan |
JPMorgan Chase Bank, N.A., the Fund's custodian |
KBRA |
Kroll Bond Rating Agency |
LIBOR |
London Inter-bank Offered Rate* |
Management Agreement |
The Management Agreement, as amended, between the Fund and the Investment Manager |
Moody’s |
Moody’s Investors Service, Inc. |
NRSRO |
Nationally recognized statistical ratings organization (for example, Moody’s, Fitch or S&P) |
NYSE |
New York Stock Exchange |
PwC |
PricewaterhouseCoopers LLP |
REIT |
Real estate investment trust |
REMIC |
Real estate mortgage investment conduit |
S&P |
S&P Global Ratings, a division of S&P Global Inc. (“Standard & Poor’s”
and “S&P” are trademarks of S&P Global Inc. and have been
licensed for use by the Investment Manager. The Columbia Funds are
not sponsored, endorsed, sold or promoted by S&P Global
Ratings, and S&P Global Ratings makes no representation
regarding the advisability of investing in the Columbia
Funds.) |
SAI |
This Statement of Additional Information, as amended and supplemented from time-to-time |
SEC |
United States Securities and Exchange Commission |
Shares |
Shares of the Fund |
SOFR |
Secured Overnight Financing Rate |
Transfer Agent |
Equiniti Trust Company, LLC (formerly known as American Stock Transfer & Trust Company, LLC) |
Transfer Agency and Registrar Agreement |
The Transfer Agency Agreement, as amended, between the Fund and the Transfer Agent |
Fund |
Fiscal Year End |
Prospectus Date |
Diversified* |
Columbia Seligman Premium Technology Growth Fund, Inc. |
December 31 |
TBD |
No |
Type of Investment |
Columbia Seligman Premium Technology Growth Fund |
Asset-Backed Securities |
Yes |
Bank Obligations (Domestic and Foreign) |
Yes |
Collateralized Bond Obligations |
Yes |
Commercial Paper |
Yes |
Common Stock |
Yes |
Convertible Securities |
Yes |
Corporate Debt Securities |
Yes |
Custody Receipts and Trust Certificates |
Yes |
Debt Obligations |
Yes |
Depositary Receipts |
Yes |
Type of Investment |
Columbia Seligman Premium Technology Growth Fund |
Derivatives |
Yes |
Dollar Rolls |
Yes |
Exchange-Traded Notes |
Yes |
Foreign Currency Transactions |
Yes |
Foreign Securities |
Yes |
Guaranteed Investment Contracts (Funding Agreements) |
Yes |
High-Yield Securities |
Yes |
Illiquid Investments |
Yes |
Inflation Protected Securities |
Yes |
Initial Public Offerings |
Yes |
Inverse Floaters |
Yes |
Investment in Other Investment Companies (Including ETFs)
|
Yes |
Listed Private Equity Funds |
Yes |
Money Market Instruments |
Yes |
Mortgage-Backed Securities |
Yes |
Municipal Securities |
Yes |
Participation Interests |
Yes |
Partnership Securities |
Yes |
Preferred Stock |
Yes |
Private Placement and Other Restricted Securities |
Yes |
Real Estate Investment Trusts |
Yes |
Repurchase Agreements |
Yes |
Reverse Repurchase Agreements |
Yes |
Short Sales |
Yes |
Sovereign Debt |
Yes |
Standby Commitments |
Yes |
U.S. Government and Related Obligations |
Yes |
Variable- and Floating-Rate Obligations |
Yes |
Warrants and Rights |
Yes |
|
Asset (in Millions) |
Annual rate at each asset level |
Columbia Seligman Premium Technology Growth Fund, Inc. |
$0 - $500 |
1.060% |
˃$500 - $1,000 |
1.055% | |
˃$1,000 - $3,000 |
1.050% | |
˃$3,000 - $4,000 |
1.010% | |
˃$4,000 - $6,000 |
0.960% |
|
Asset
(in Millions) |
Annual rate at each asset level |
|
˃$6,000 - $12,000 |
0.910% |
|
˃$12,000 - $20,000 |
0.900% |
|
˃$20,000 - $24,000 |
0.890% |
|
˃$24,000 - $50,000 |
0.880% |
|
˃$50,000 |
0.850% |
|
Management
Services Fees Paid | ||
Fund |
|
|
|
For Funds with fiscal period ending December 31
|
2023 |
2022 |
2021 |
Columbia Seligman Premium Technology Growth Fund, Inc. |
$4,580,664 |
$4,704,400 |
$5,496,087 |
|
|
Other
Accounts Managed (excluding the Fund) |
| ||
Fund |
Portfolio Manager |
Number and type
of account* |
Approximate
Total Net Assets
(excluding the fund) |
Performance
Based
Accounts** |
Ownership of Fund Shares |
Information is as of December 31, 2023, unless otherwise noted
| |||||
Columbia Seligman Premium Technology Growth Fund |
Paul Wick |
4 RICs
3 PIVs
8 other accounts |
$13.82 billion
$1.94 billion
$1.73 billion |
2 PIVs -$998.01M
1 other account –
$182.78M |
None |
Braj Agrawal |
15 other accounts |
$1.45 million |
None |
None | |
Christopher Boova |
2 RICs
6 other accounts |
$2.28 billion
$6.77 million |
None |
None | |
Jeetil Patel |
1 RIC
10 other accounts |
$11.50 billion
$6.54 million |
None |
None | |
Vimal Patel |
3 RICs
8 other accounts |
$13.79 billion
$6.36 million |
None |
None | |
Shekhar Pramanick |
4 RICs 6 other accounts |
$13.82 billion $14.05 million |
None |
None |
Name, Address, Year of Birth |
Position Held
with the Fund and
Length of Service |
Principal Occupation(s)
During the Past Five Years
and Other Relevant
Professional Experience |
Number of
Funds in the
Columbia Funds
Complex
Overseen |
Other Directorships Held
by Director During the
Past Five Years and Other
Relevant Board
Experience |
Committee Assignments |
George S. Batejan c/o Columbia Management Investment Advisers, LLC, 290 Congress Street, Boston, MA 02210 1954 |
Director since January 2018 |
Executive Vice President, Global Head of Technology and Operations, Janus Capital Group, Inc., 2010- 2016 |
161 |
Former Chairman of the Board, NICSA (National Investment Company Services Association) (Executive Committee, Nominating Committee and Governance Committee), 2014- 2016; former Director, Intech Investment Management, 2011- 2016; former Board Member, Metro Denver Chamber of Commerce, 2015-2016; former Advisory Board Member, University of Colorado Business School, 2015-2018; former Board Member, Chase Bank International, 1993- 1994 |
Compliance,
Contracts, Investment
Review |
Name, Address, Year of Birth |
Position Held
with the Fund and
Length of Service |
Principal Occupation(s)
During the Past Five Years
and Other Relevant
Professional Experience |
Number of
Funds in the
Columbia Funds
Complex
Overseen |
Other Directorships Held
by Director During the
Past Five Years and Other
Relevant Board
Experience |
Committee Assignments |
Kathleen Blatz c/o Columbia Management Investment Advisers, LLC, 290 Congress Street, Boston, MA 02210 1954 |
Director since
October 2009 |
Attorney, specializing in
arbitration and mediation;
Trustee of Gerald
Rauenhorst 1982 Trusts,
since 2020; Chief Justice,
Minnesota Supreme Court,
1998-2006; Associate
Justice, Minnesota
Supreme Court, 1996-
1998; Fourth Judicial
District Court Judge,
Hennepin County, 1994-
1996; Attorney in private
practice and public service,
1984-1993; State
Representative, Minnesota
House of Representatives,
1979-1993, which included
service on the Tax and
Financial Institutions and
Insurance Committees;
Member and Interim Chair,
Minnesota Sports Facilities
Authority, January-July
2017; Interim President
and Chief Executive Officer,
Blue Cross and Blue Shield
of Minnesota (health care
insurance), February-July
2018, April-October 2021 |
161 |
Former Trustee, Blue
Cross and Blue Shield
of Minnesota, 2009-
2021 (Chair of the
Business Development
Committee, 2014-
2017; Chair of the
Governance Committee,
2017-2019); former
Member and Chair of
the Board, Minnesota
Sports Facilities
Authority, January 2017-
July 2017; former
Director, Robina
Foundation, 2009-2020
(Chair, 2014-2020);
Director, Richard M.
Schulze Family
Foundation, since 2021 |
Compliance, Contracts,
Investment Review |
Pamela G. Carlton c/o Columbia Management Investment Advisers, LLC, 290 Congress Street, Boston, MA 02210 1954 |
Director since
October 2009;
Chair of the
Board since
January 2023 |
President, Springboard-
Partners in Cross Cultural
Leadership (consulting
company), since 2003;
Managing Director of US
Equity Research, JP Morgan
Chase, 1999-2003;
Director of US Equity
Research, Chase Asset
Management, 1996-1999;
Co-Director Latin America
Research, 1993-1996,
COO Global Research,
1992-1996, Co-Director of
US Research, 1991-1992,
Investment Banker, 1982-
1991, Morgan Stanley;
Attorney, Cleary Gottlieb
Steen & Hamilton LLP,
1980-1982 |
161 |
Trustee, New York
Presbyterian Hospital
Board, since 1996;
Director, DR Bank (Audit
Committee, since 2017
and Audit Committee
Chair, since November
2023); Director,
Evercore Inc. (Audit
Committee, Nominating
and Governance
Committee) (financial
services company),
since 2019; Director,
Apollo Commercial Real
Estate Finance, Inc.
(Chair, Nominating and
Governance
Committee), since
2021; the Governing
Council of the
Independent Directors
Council (IDC), since
2021 |
Board
Governance, Contracts,
Investment Review |
Janet Langford Carrig c/o Columbia Management Investment Advisers, LLC, 290 Congress Street Boston, MA 02210 1957 |
Director since January 2023 |
Senior Vice President, General Counsel and Corporate Secretary, ConocoPhillips (independent energy company), September 2007-October 2018 |
161 |
Director, EQT Corporation (natural gas producer), since 2019; former Director, Whiting Petroleum Corporation (independent oil and gas company), 2020- 2022 |
Board
Governance, Contracts,
Investment Review |
Name, Address, Year of Birth |
Position Held
with the Fund and
Length of Service |
Principal Occupation(s)
During the Past Five Years
and Other Relevant
Professional Experience |
Number of
Funds in the
Columbia Funds
Complex
Overseen |
Other Directorships Held
by Director During the
Past Five Years and Other
Relevant Board
Experience |
Committee Assignments |
Patricia M. Flynn c/o Columbia Management Investment Advisers, LLC, 290 Congress Street,
Boston, MA 02210 1950 |
Director since
October 2009 |
Professor Emeritus of
Economics and
Management, Bentley
University since 2023;
Professor of Economics
and Management, Bentley
University, 1976-2023;
Dean, McCallum Graduate
School of Business,
Bentley University, 1992-
2002 |
161 |
Former Trustee, MA
Taxpayers Foundation,
1997-2022; former
Director, The MA
Business Roundtable,
2003-2019; former
Chairperson, Innovation
Index Advisory
Committee, MA
Technology
Collaborative, 1997-
2020 |
Audit, Contracts,
Investment Review |
Brian J. Gallagher c/o Columbia Management Investment Advisers, LLC, 290 Congress Street, Boston, MA 02210 1954 |
Director since
January 2020 |
Retired; Partner with
Deloitte & Touche LLP and
its predecessors, 1977-
2016 |
161 |
Trustee, Catholic
Schools Foundation,
since 2004 |
Audit, Board
Governance, Contracts,
Investment Review |
Douglas A. Hacker c/o Columbia Management Investment Advisers, LLC, 290 Congress Street Boston, MA 02210 1955 |
Director since January 2022 |
Independent business executive since May 2006; Executive Vice President – Strategy of United Airlines, December 2002-May 2006; President of UAL Loyalty Services (airline marketing company), September 2001-December 2002; Executive Vice President and Chief Financial Officer of United Airlines, July 1999-September 2001 |
161 |
Director, SpartanNash Company (food distributor), since November 2013 (Chair of the Board since May 2021); Director, Aircastle Limited (aircraft leasing), since August 2006 (Chair of Audit Committee); former Director, Nash Finch Company (food distributor), 2005-2013; former Director, SeaCube Container Leasing Ltd. (container leasing), 2010-2013; and former Director, Travelport Worldwide Limited (travel information technology), 2014-2019 |
Audit, Board
Governance, Contracts,
Investment Review |
Name, Address, Year of Birth |
Position Held
with the Fund and
Length of Service |
Principal Occupation(s)
During the Past Five Years
and Other Relevant
Professional Experience |
Number of
Funds in the
Columbia Funds
Complex
Overseen |
Other Directorships Held
by Director During the
Past Five Years and Other
Relevant Board
Experience |
Committee Assignments |
David M. Moffett c/o Columbia Management Investment Advisers, LLC, 290 Congress Street Boston, MA 02210 1952 |
Director since
January 2024 |
Retired; former Chief
Executive Officer of Freddie
Mac and Chief Financial
Officer of U.S. Bank |
161 |
Director, CSX
Corporation
(transportation
suppliers); Director,
PayPal Holdings Inc.
(payment and data
processing services);
former Director, eBay
Inc. (online trading
community), 2007-
2015; and former
Director, CIT Bank, CIT
Group Inc. (commercial
and consumer finance),
2010-2016; former
Senior Adviser to The
Carlyle Group (financial
services), March 2008-
September 2008;
former Governance
Consultant to
Bridgewater Associates
(investment company),
January 2013-
December 2015 |
Audit, Contracts,
Investment Review |
Catherine James Paglia c/o Columbia Management Investment Advisers, LLC, 290 Congress Street, Boston, MA 02210 1952 |
Director since
October 2009 |
Director, Enterprise Asset
Management, Inc. (private
real estate and asset
management company),
since September 1998;
Managing Director and
Partner, Interlaken Capital,
Inc., 1989-1997; Vice
President, 1982-1985,
Principal, 1985-1987,
Managing Director, 1987-
1989, Morgan Stanley;
Vice President, Investment
Banking, 1980-1982,
Associate, Investment
Banking, 1976-1980, Dean
Witter Reynolds, Inc. |
161 |
Director, Valmont
Industries, Inc.
(irrigation systems
manufacturer), since
2012; Trustee, Carleton
College (on the
Investment Committee),
since 1987; Trustee,
Carnegie Endowment
for International Peace
(on the Investment
Committee), since
2009 |
Board
Governance, Compliance,
Contracts, Investment
Review |
Sandra L. Yeager c/o Columbia Management Investment Advisers, LLC, 290 Congress Street,
Boston, MA 02210 1964 |
Director since June 2020 |
Retired; President and founder, Hanoverian Capital, LLC (SEC registered investment advisor firm), 2008-2016; Managing Director, DuPont Capital, 2006-2008; Managing Director, Morgan Stanley Investment Management, 2004-2006; Senior Vice President, Alliance Bernstein, 1990- 2004 |
161 |
Former Director, NAPE (National Alliance for Partnerships in Equity) Education Foundation, October 2016-October 2020; Advisory Board, Jennersville YMCA, June 2022-June 2023 |
Audit,
Contracts, Investment
Review |
Name, Address, Year of Birth |
Position Held
with the Fund and
Length of Service |
Principal Occupation(s)
During the Past Five Years
and Other Relevant
Professional Experience |
Number of
Funds in the
Columbia Funds
Complex*
Overseen |
Other Directorships Held
by Director During the
Past Five Years and Other
Relevant Board
Experience |
Committee Assignments |
Daniel J. Beckman c/o Columbia Management Investment Advisers, LLC 290 Congress Street Boston, MA 02210
1962 |
Director since November 2021 and President since June 2021 |
President and Principal Executive Officer of the Columbia Funds, since June 2021; Vice President, Columbia Management Investment Advisers, LLC, since April 2015; formerly, Vice President – Head of North America Product, Columbia Management Investment Advisers, LLC, April 2015 – December 2023; President and Principal Executive Officer, Columbia Acorn/Wanger Funds, since July 2021 |
161 |
Director, Ameriprise Trust Company, since October 2016; Director, Columbia Management Investment Distributors, Inc., since November 2018; Board of Governors, Columbia Wanger Asset Management, LLC, since January 2022 |
None |
Name, Address
and Year of Birth |
Position and Year
First Appointed to
Position for any Fund in the Columbia Funds Complex or a Predecessor Thereof |
Principal Occupation(s) During Past Five Years |
Michael G. Clarke 290 Congress Street Boston, MA 02210 1969 |
Chief Financial Officer
and Principal Financial
Officer (2009); Senior
Vice President (2019);
and Treasurer and Chief
Accounting Officer
(Principal Accounting
Officer) (2024) |
Senior Vice President and North America Head of Operations &
Investor Services, Columbia Management Investment Advisers,
LLC, since June 2023 (previously Senior Vice President and Head
of Global Operations & Investor Services, March 2022 – June
2023, Vice President, Head of North America Operations, and Co-
Head of Global Operations, June 2019 - February 2022 and Vice
President – Accounting and Tax, May 2010 - May 2019); senior
officer of Columbia Funds and affiliated funds, since 2002;
Director, Ameriprise Trust Company, since June 2023. |
Marybeth Pilat 290 Congress Street Boston, MA 02210 1968 |
Assistant Treasurer (2021) |
Vice President – Product Pricing and Administration, Columbia Management Investment Advisers, LLC, since May 2017. |
Name, Address and Year of Birth |
Position and Year
First Appointed to
Position for any Fund in the
Columbia Funds Complex
or a Predecessor Thereof |
Principal Occupation(s) During Past Five Years |
William F. Truscott 290 Congress Street Boston, MA 02210 1960 |
Senior Vice President
(2001) |
Formerly, Trustee/Director of Columbia Funds Complex or legacy
funds, November 2001 – January 1, 2021; Chief Executive Officer,
Global Asset Management, Ameriprise Financial, Inc., since
September 2012; Chairman of the Board and President, Columbia
Management Investment Advisers, LLC, since July 2004 and
February 2012, respectively; Chairman of the Board and Chief
Executive Officer, Columbia Management Investment Distributors,
Inc., since November 2008 and February 2012, respectively;
Chairman of the Board and Director, TAM UK International
Holdings Limited, since July 2021; formerly Chairman of the Board
and Director, Threadneedle Asset Management Holdings, Sàrl,
March 2013 – December 2022 and December 2008 – December
2022, respectively; senior executive of various entities affiliated
with Columbia Threadneedle Investments. |
Christopher O. Petersen 5228 Ameriprise
Financial Center Minneapolis, MN 55474 1970 |
Senior Vice President and
Assistant Secretary (2021) |
Formerly, Trustee/Director of funds within the Columbia Funds Complex, July 1, 2020 - November 22, 2021; Senior Vice President and Assistant General Counsel, Ameriprise Financial, Inc., since September 2021 (previously Vice President and Lead Chief Counsel, January 2015 - September 2021); formerly, President and Principal Executive Officer of the Columbia Funds, 2015 - 2021; officer of Columbia Funds and affiliated funds since 2007. |
Thomas P. McGuire 290 Congress Street
Boston, MA 02210 1972 |
Senior Vice President and
Chief Compliance Officer
(2012) |
Vice President – Asset Management Compliance, Ameriprise
Financial, Inc., since May 2010; Chief Compliance Officer,
Columbia Acorn/Wanger Funds since December 2015; formerly,
Chief Compliance Officer, Ameriprise Certificate Company,
September 2010 – September 2020. |
Ryan C. Larrenaga 290 Congress Street Boston, MA 02210 1970 |
Senior Vice President
(2017), Chief Legal
Officer (2017) and
Secretary (2015) |
Vice President and Chief Counsel, Ameriprise Financial, Inc., since August 2018 (previously Vice President and Group Counsel, August 2011 – August 2018); Chief Legal Officer, Columbia Acorn/Wanger Funds, since September 2020; officer of Columbia Funds and affiliated funds since 2005. |
Michael E. DeFao 290 Congress Street
Boston, MA 02210 1968 |
Vice President (2011)
and Assistant Secretary
(2010) |
Vice President and Chief Counsel, Ameriprise Financial, Inc., since
May 2010; Vice President, Chief Legal Officer and Assistant
Secretary, Columbia Management Investment Advisers, LLC, since
October 2021 (previously Vice President and Assistant Secretary,
May 2010 – September 2021). |
Lyn Kephart-Strong 5903 Ameriprise Financial Center Minneapolis, MN 55474 1960 |
Vice President (2015) |
Vice President, Global Investment Operations Services, Columbia Management Investment Advisers, LLC, since 2010; Director (since January 2007) and President (since October 2014), Columbia Management Investment Services Corp.; Director (since December 2017) and President (since January 2017), Ameriprise Trust Company. |
Board Member |
Dollar Range of Equity
Securities Owned by
Director of the Fund |
Aggregate Dollar Range of Equity
Securities in all Funds
in the Columbia Funds
Complex Overseen by the Director |
George S. Batejan |
$1-$10,000 |
Over $100,000(a) |
Kathleen Blatz |
$1-$10,000 |
Over $100,000 |
Pamela G. Carlton |
$50,001-$100,000 |
Over $100,000(a) |
Janet Langford Carrig |
$1-$10,000 |
Over $100,000(a) |
Patricia M. Flynn |
$1-$10,000 |
Over $100,000(a) |
Brian J. Gallagher |
$1-$10,000 |
Over $100,000(a) |
Douglas A. Hacker |
$1-$10,000 |
Over $100,000 |
David M. Moffett(b) |
$0 |
Over $100,000(a) |
Catherine James Paglia |
$1-$10,000 |
Over $100,000(a) |
Board Member |
Dollar Range of Equity
Securities Owned by
Director of the Fund |
Aggregate Dollar Range of Equity
Securities in all Funds
in the Columbia Funds
Complex Overseen by the Director |
Sandra L. Yeager |
$10,001-$50,000 |
Over $100,000(a) |
Interested Director |
Dollar Range of Equity
Securities Owned by
Director of the Fund |
Aggregate Dollar Range of Equity
Securities Owned by Director or Nominee of All Funds Overseen by Director of the Columbia Funds
Complex |
Daniel J. Beckman |
$10,001-$50,000 |
Over $100,000(a) |
Director Name(a)
|
Total Cash
Compensation from the Columbia Funds Complex
Paid to Director(b) |
Amount Deferred
from Total Compensation(c) |
George S. Batejan |
$469,000 |
$23,450 |
Kathleen Blatz |
$481,000 |
$0 |
Pamela G. Carlton |
$560,000 |
$0 |
Janet Langford Carrig |
$484,000 |
$484,000 |
Patricia M. Flynn |
$451,000 |
$0 |
Brian J. Gallagher |
$499,000 |
$249,500 |
Douglas A. Hacker |
$466,000 |
$0 |
David M. Moffett(d) |
$456,000 |
$0 |
Catherine James Paglia |
$466,000 |
$0 |
Sandra L. Yeager |
$484,000 |
$242,000 |
Director Name |
Total Cash
Compensation from the Fund
Paid to Director |
Amount Deferred
from Compensation |
George S. Batejan(a) |
$3,553 |
$178 |
Kathleen Blatz |
$3,553 |
$0 |
Pamela G. Carlton(b) |
$3,553 |
$0 |
Janet Langford Carrig(c)
|
$3,553 |
$3,553 |
Patricia M. Flynn(d) |
$3,553 |
$0 |
Brian J. Gallagher(e) |
$3,553 |
$1,777 |
Douglas A. Hacker |
$3,553 |
$0 |
David M. Moffett(f) |
$0 |
$0 |
Catherine James Paglia(g) |
$3,553 |
$0 |
Sandra Yeager(h) |
$3,553 |
$1,777 |
|
Total Brokerage
Commissions | ||
Fund |
2023 |
2022 |
2021 |
For Funds with fiscal period ending December 31
| |||
Columbia Seligman Premium Technology Growth Fund, Inc. |
$132,756 |
$87,967 |
$116,373 |
|
Brokerage
directed for research | |
Fund |
Amount of
Transactions |
Amount of
Commissions Imputed or Paid |
For Funds with fiscal period ending December 31
| ||
Columbia Seligman Premium Technology Growth Fund, Inc. |
$136,499,843 |
$27,539 |
Fund |
Issuer |
Value of securities owned at end of fiscal period |
For Funds with fiscal period ending December 31,
2023 | ||
Seligman Premium Technology Growth Fund, Inc. |
None |
N/A |
Long-Term Rating |
Short-Term Rating |
AAA |
F1+ |
AA+ |
F1+ |
AA |
F1+ |
AA– |
F1+ |
A+ |
F1 or F1+ |
A |
F1 or F1+ |
A– |
F2 or F1 |
BBB+ |
F2 or F1 |
BBB |
F3 or F2 |
BBB– |
F3 |
BB+ |
B |
BB |
B |
BB– |
B |
B+ |
B |
B |
B |
B– |
B |
CCC+ / CCC / CCC– |
C |
CC |
C |
C |
C |
RD / D |
RD / D |
Long-Term Rating |
Short-Term Rating |
AAA AA+
AA AA– |
K1+ |
A+ |
K1+ or K1 |
A |
K1 |
A– |
K1 or K2 |
BBB+ |
K2 |
BBB |
K2 or K3 |
BBB– |
K3 |
BB+
BB BB–
B+ B
B– |
B |
CCC+ CCC
CCC– CC
C |
C |
D |
D |
1 Overview of key principles and approach |
B-1 |
2 Role, structure and operation of boards |
B-2 |
3 Board committees |
B-5 |
4 Compensation |
B-6 |
5 Audit, risk and control |
B-7 |
6 Shareholder rights |
B-8 |
7 Reporting |
B-9 |
8 Social and environmental factors |
B-11 |
9 Voting matters |
B-13 |
Exhibit
Number |
Exhibit Description |
Filed Herewith or
Incorporated by
Reference |
Information About the
Filing that Includes the Document Incorporated by Reference | ||||
Registrant
that Made
the Filing |
File No.
of Such
Registrant |
Type of
Filing |
Exhibit of
Document
in that
Filing |
Filing
Date | |||
(a)(1) |
Incorporated by
Reference |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
333-161752 |
Registration
Statement on Form
N-2 |
(a) |
9/4/2009 | |
(a)(2) |
Incorporated by
Reference |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
333-161752 |
Post-Effective
Amendment #1 on
Form N-2 |
(a)(1) |
3/14/2016 | |
(b) |
Incorporated by
Reference |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
333-161752 |
Post-Effective
Amendment #1 on
Form N-2 |
(b) |
3/14/2016 | |
(c) |
Not applicable |
|
|
|
|
|
|
(d) |
Not applicable |
|
|
|
|
|
|
(e) |
Incorporated by
Reference |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
333-161752 |
Pre-Effective
Amendment #2 on
Form N-2 |
(e) |
10/22/2009 | |
(f) |
Not applicable |
|
|
|
|
|
|
(g)(1) |
Incorporated by
Reference |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
333-161752 |
Post-Effective
Amendment #2 on
Form N-2 |
(g) |
4/28/2016 | |
(g)(2) |
Filed Herewith |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
|
|
(g)(2) |
6/26/2024 | |
(h)(1) |
Incorporated by
Reference |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
333-161752 |
Pre-Effective
Amendment #2 on
Form N-2 |
(h)(1) |
10/22/2009 | |
(h)(2) |
Incorporated by Reference |
Columbia Seligman Premium Technology Growth Fund, Inc. |
333-161752 |
Pre-Effective Amendment #2 on Form N-2 |
(h)(2) |
10/22/2009 |
Exhibit
Number |
Exhibit Description |
Filed Herewith or
Incorporated by
Reference |
Information About the
Filing that Includes the Document Incorporated by Reference | ||||
Registrant
that Made
the Filing |
File No.
of Such
Registrant |
Type of
Filing |
Exhibit of
Document
in that
Filing |
Filing
Date | |||
(h)(3) |
Incorporated by
Reference |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
333-161752 |
Pre-Effective
Amendment #2 on
Form N-2 |
(h)(3) |
10/22/2009 | |
(h)(4) |
Incorporated by
Reference |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
333-161752 |
Pre-Effective
Amendment #4 on
Form N-2 |
(h)(4) |
11/24/2009 | |
(h)(5) |
Incorporated by
Reference |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
333-161752 |
Pre-Effective
Amendment #4 on
Form N-2 |
(h)(5) |
11/24/2009 | |
(h)(6) |
Incorporated by
Reference |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
333-161752 |
Pre-Effective
Amendment #4 on
Form N-2 |
(h)(6) |
11/24/2009 | |
(h)(7) |
Incorporated by
Reference |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
333-161752 |
Pre-Effective
Amendment #4 on
Form N-2 |
(h)(7) |
11/24/2009 | |
(h)(8) |
Incorporated by
Reference |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
333-161752 |
Pre-Effective
Amendment #4 on
Form N-2 |
(h)(8) |
11/24/2009 | |
(h)(9) |
Filed Herewith |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
|
|
(h)(9) |
6/26/2024 | |
(h)(10) |
Sub-Placement Agent Agreement |
To be filed by
amendment |
|
|
|
|
|
(i) |
Incorporated by
Reference |
Columbia Funds
Series Trust II |
333-131683 |
Post-Effective
Amendment #218
on Form N-1A |
(f) |
2/25/2021 | |
(j) |
Incorporated by
Reference |
Columbia Funds
Series Trust |
333-89661 |
Post-Effective
Amendment #93
on Form N-1A |
(g)(3) |
5/27/2011 | |
(k)(1) |
Incorporated by
Reference |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
333-16175 |
Pre-Effective
Amendment #2 on
Form N-2 |
(k)(1) |
10/22/2009 | |
(k)(2) |
Incorporated by
Reference |
Columbia Funds
Series Trust II |
333-131683 |
Post-Effective
Amendment #179
on Form N-1A |
(h)(11) |
5/25/2018 | |
(k)(2)(i) |
Incorporated by
Reference |
Columbia Funds
Series Trust |
333-89661 |
Post-Effective
Amendment #207
on Form N-1A |
(h)(9)(i) |
7/26/2023 | |
(k)(3) |
Incorporated by Reference |
Tri-Continental Corporation |
333-255533 |
Post-Effective Amendment #2 on Form N-2 |
(k)(3) |
6/2/2022 |
Exhibit
Number |
Exhibit Description |
Filed Herewith or
Incorporated by
Reference |
Information About the
Filing that Includes the Document Incorporated by Reference | ||||
Registrant
that Made
the Filing |
File No.
of Such
Registrant |
Type of
Filing |
Exhibit of
Document
in that
Filing |
Filing
Date | |||
(k)(4) |
Incorporated by
Reference |
Tri-Continental
Corporation |
333-255533 |
Post-Effective
Amendment #2 on
Form N-2 |
(k)(4) |
6/2/2022 | |
(l)(1) |
Incorporated by
Reference |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
333-161752 |
Pre-Effective
Amendment #3 on
Form N-2 |
(l)(1) |
10/23/2009 | |
(l)(2) |
Incorporated by
Reference |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
333-161752 |
Pre-Effective
Amendment #3 on
Form N-2 |
(l)(2) |
10/23/2009 | |
(l)(3) |
Filed Herewith |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
|
|
(l)(3) |
6/26/2024 | |
(l)(4) |
Filed Herewith |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
|
|
(l)(4) |
6/26/2024 | |
(m) |
Not Applicable |
|
|
|
|
|
|
(n) |
Filed Herewith |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
|
|
(n) |
6/26/2024 | |
(o) |
Not Applicable |
|
|
|
|
|
|
(p) |
Incorporated by
Reference |
Columbia
Seligman Premium
Technology
Growth Fund, Inc. |
333-161752 |
Pre-Effective
Amendment #2 on
Form N-2 |
(p) |
10/22/2009 | |
(q) |
Not Applicable |
|
|
|
|
|
|
(r)(1) |
Incorporated by
Reference |
Columbia Funds
Variable Series
Trust II |
333-146374 |
Post-Effective
Amendment #68
on Form N-1A |
(p)(1) |
4/26/2019 | |
(r)(2) |
Incorporated by
Reference |
Columbia Funds
Series Trust II |
333-131683 |
Post-Effective
Amendment #241
on Form N-1A |
(p)(2) |
12/21/2023 | |
(s) |
Filed Herewith |
Columbia Seligman Premium Technology Growth Fund, Inc. |
|
|
(s) |
6/26/2024 |
|
|
SEC Registration Fees |
$0 |
|
|
FINRA Fees |
$0 |
New York Stock Exchange Fees |
$0 |
Costs of Printing (other than stock certificates) |
$0 |
Accounting Fees and Expenses |
$0 |
Legal Fees and Expenses |
$0 |
Miscellaneous |
$0 |
Total |
$0 |
Title of Class |
Number of Recordholders |
Common Stock |
6 |
Columbia Seligman Premium Technology Growth Fund, Inc. | |
By: |
/s/ Daniel J. Beckman |
|
Daniel J. Beckman Director and President |
Signature |
Capacity |
Signature |
Capacity |
/s/ Daniel J. Beckman |
Director and President
(Principal Executive Officer) |
/s/
Patricia M. Flynn* |
Director |
Daniel J. Beckman |
Patricia M. Flynn | ||
/s/ Michael G. Clarke* |
Chief Financial Officer,
Principal Financial Officer, Senior Vice
President, Treasurer and Chief
Accounting Officer (Principal
Accounting Officer) |
/s/ Brian
J. Gallagher* |
Director |
Michael G. Clarke |
Brian J. Gallagher | ||
/s/ Pamela G. Carlton* |
Director and Chair of the Board |
/s/
Douglas A. Hacker* |
Director |
Pamela G. Carlton |
Douglas A. Hacker | ||
/s/ George S. Batejan* |
Director |
/s/ David
M. Moffett* |
Director |
George S. Batejan |
David Moffett | ||
/s/ Kathleen A. Blatz* |
Director |
/s/
Catherine James Paglia* |
Director |
Kathleen A. Blatz |
Catherine James Paglia | ||
/s/ Janet Langford Carrig* |
Director |
/s/
Sandra Yeager* |
Director |
Janet Langford Carrig |
Sandra Yeager |
* |
By: Name: |
/s/
Joseph D’Alessandro |
|
Joseph D’Alessandro** Attorney-in-fact |
| ||
** |
Executed by Joseph D’Alessandro on behalf of Michael G. Clarke pursuant to a Power of Attorney, dated February 1, 2021,
on behalf of the Directors pursuant to a Power of Attorney, dated January 1, 2023 and on
behalf of David M. Moffett pursuant to a Power of Attorney, dated December 20,
2023. |
/s/ Pamela G. Carlton |
Director and Chair of the Board |
/s/
Patricia M. Flynn |
Director |
Pamela G. Carlton |
Patricia M. Flynn | ||
/s/ George S. Batejan |
Director |
/s/ Brian
J. Gallagher |
Director |
George S. Batejan |
Brian J. Gallagher | ||
/s/ Daniel J. Beckman |
Director |
Douglas
A. Hacker |
Director |
Daniel J. Beckman |
Douglas A. Hacker | ||
/s/ Kathleen A. Blatz |
Director |
/s/
Catherine James Paglia |
Director |
Kathleen A. Blatz |
Catherine James Paglia | ||
/s/ Janet Langford Carrig |
Director |
/s/
Sandra L. Yeager |
Director |
Janet Langford Carrig |
Sandra L. Yeager |
(g)(2) |
Schedule A to the Management Agreement dated May 1, 2016, between Columbia Management Investment Advisers, LLC and
the Registrant |
(h)(9) |
Distribution Agreement between the Registrant and ALPS Distributors, Inc. relating to Registrant's Rule 415 “at the market”
offering |
(l)(3) |
Form of Opinion and Consent of Ropes & Gray LLP |
(l)(4) |
Opinion and Consent of Venable LLP |
(n) |
Consent of Independent Registered Public Accounting Firm |
EX-FILING FEES |
Calculation of Filing Fee Table |
Exhibit (g)(2)
SCHEDULE A
Fee Schedule
(Effective [DATE])
The asset charge for each calendar day of each year shall be equal to the total of 1/365th (1/366th in each leap year) of the amount computed in accordance with the fee schedule in the table below:
Net Assets (millions) |
Annual rate at each asset level Asset Charge |
|||
$0 - $500 |
1.060 | % | ||
> $500 - $1,000 |
1.055 | % | ||
> $1,000 - $3,000 |
1.050 | % | ||
> $3,000 - $4,000 |
1.010 | % | ||
> $4,000 - $6,000 |
0.960 | % | ||
> $6,000 - $12,000 |
0.910 | % | ||
> $12,000 - $20,000 |
0.900 | % | ||
> $20,000 - $24,000 |
0.890 | % | ||
> $24,000 - $50,000 |
0.880 | % | ||
> $50,000 |
0.850 | % |
The computation shall be made for each calendar day on the basis of managed assets as of the close of the preceding day. In the case of the suspension of the computation of net asset value, the fee for each calendar day during such suspension shall be computed as of the close of business on the last full business day on which the managed assets were computed. Managed assets shall mean the net asset value of the Funds common stock plus the liquidation preference of any issued and outstanding preferred stock of the fund and the principal amount of any borrowings used for leverage.
IN WITNESS THEREOF, the parties hereto have executed the foregoing Schedule A as of __________, 2024.
COLUMBIA SELIGMAN PREMIUM TECHNOLOGY GROWTH FUND, INC. | ||
By: |
| |
Name: | ||
Title: | ||
COLUMBIA MANAGEMENT INVESTMENT ADVISERS, LLC | ||
By: |
| |
Name: | ||
Title: |
Exhibit (h)(9)
DISTRIBUTION AGREEMENT
This DISTRIBUTION AGREEMENT (this Agreement) made as of June 20, 2024 by and between the Columbia Seligman Premium Technology Growth Fund, Inc., a Maryland corporation (the Fund), and ALPS Distributors, Inc., a Colorado corporation (the Distributor).
WITNESSETH:
WHEREAS, the Fund is registered under the Investment Company Act of 1940, as amended, and the rules and regulations thereunder (collectively, the Investment Company Act), as a diversified, closed-end, management investment company; and
WHEREAS, the Fund has filed a registration statement on Form N-2 (File No. 333-161752 and 811-22328) (the Registration Statement) pursuant to the Investment Company Act and the Securities Act of 1933, as amended, and the rules and regulations thereunder (collectively, the Securities Act), to register shares of common stock, $0.01 par value, of the Fund (the Common Shares), which may be issued and sold from time to time through various specified transactions, including at-the-market (ATM) offerings pursuant to Rule 415(a)(4) under the Securities Act; and
WHEREAS, the Distributor is registered as a broker-dealer under the provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (collectively, the Exchange Act), and is a member in good standing of the Financial Industry Regulatory Authority, Inc. (FINRA); and
WHEREAS, the Fund and the Distributor wish to enter into a distribution agreement with each other with respect to ATM offerings, from time to time, of the Common Shares.
NOW THEREFORE, the parties agree as follows:
Section 1. Appointment of the Distributor; ATM Offerings.
(a) Subject to the terms and conditions of this Agreement, the Fund hereby appoints the Distributor as its principal underwriter and placement agent for up to 8,000,000 Common Shares of the Fund to be offered pursuant to the Registration Statement through ATM offerings from time to time (the Shares) and the Fund agrees that it will issue such Shares as the Distributor may sell. The Distributor agrees to enter into sub-placement agent agreements with selected dealers (Sub-Placement Agent Agreements), each of whom shall be registered as a broker-dealer under the provisions of the Exchange Act and a member in good standing of FINRA who will use reasonable efforts to identify opportunities for the sale of Shares (each, a sub-placement agent), but neither the Distributor nor any sub-placement agent is obligated to sell any specific number of the Shares (though the Distributor will only be authorized to sell on any Offering Date (as defined below) the maximum number of
Shares agreed to with the Fund pursuant to Section 1(d) hereof). The Distributor will not purchase any Shares for its own account. The Shares will only be sold on such days as shall be agreed to by the Distributor and the Fund (each, an Offering Date). The Distributor hereby accepts such appointment.
(b) The Distributor acknowledges that Shares will be offered and sold only as set forth from time to time in the Registration Statement including, without limitation, pricing of Shares, handling of investor funds and payment of sales commissions.
(c) The Fund may suspend or terminate any ATM offering of its Shares at any time. Upon notice to the Distributor of the terms of such suspension or termination, the Distributor shall suspend the ATM offering of Shares in accordance with such terms until the Fund notifies the Distributor that such ATM offering may be resumed; provided, however, that such suspension or termination shall not affect or impair the parties respective obligations with respect to the Shares sold hereunder prior to the giving of such notice.
(d) The price per Share shall be determined by the Fund together with the Distributor or any sub-placement agent by reference to trades in the Common Shares on the primary exchange for the Common Shares. In no event shall the price per Share be less than the then current net asset value per Common Share (which net asset value shall be determined as of a time within forty-eight hours, excluding Sundays and holidays, next preceding the time of such determination) plus the per Share amount of the commission to be paid to the Distributor (the Minimum Price). The Fund may establish a minimum sales price per Share on any Offering Date in excess of the Minimum Price (the Minimum Sales Price), and the Fund shall communicate such Minimum Sales Price to the Distributor. The Fund shall have sole discretion to establish a Minimum Sales Price for any Offering Date and may consider, among other factors, the degree to which the market price per Common Share exceeds the Funds net asset value per Common Share, and the amount of assets the Fund desires to raise through ATM offerings. The Distributor shall suspend the sale of Shares if the per share price of the Shares is less than the Minimum Price or the Minimum Sales Price. The Distributor or any sub-placement agent shall, together with the Fund, determine the maximum number of Shares to be sold through the Distributor or through such sub-placement agent for any Offering Date, and the Distributor or such sub-placement agent shall not be authorized to sell Shares on any Offering Date in excess of such maximum.
(e) The Distributor will confirm to the Fund, following the close of trading on the Funds primary exchange on each Offering Date for the Shares, the number of Shares sold through the Distributor and through any sub-placement agent, the time of sale, the gross sales price per Share and the compensation payable to the Distributor and such sub-placement agent, or to which the Distributor and such sub-placement agent are entitled with respect to such sales. The Fund reserves the right to reject any order in whole or in part.
(f) Settlement for sales of the Shares pursuant to this Section 1 will occur on the earlier of: (i) the date agreed upon by the parties hereto; or (ii) the latest day for settlement on the customary settlement cycle in the jurisdiction(s) where any of such Shares are customarily traded (each such day, a Settlement Date). On each Settlement Date, the Shares sold through the Distributor and through any sub-placement agent for settlement on
2
such date shall be delivered by the Fund at the Distributors request to such sub-placement agents account at The Depository Trust Company through its Deposit and Withdrawal at Custodian System or by such other means of delivery as may be mutually agreed upon by the parties, against payment of the gross sales proceeds for the sale of such Shares, less the sales commission to be paid to the Distributor and such sub-placement agent.
(g) In selling Shares, the Distributor shall act solely as an agent of the Fund and not as principal.
Section 2. Representations and Warranties by the Fund. The Fund represents, warrants to and agrees with the Distributor, as of the date hereof and as of each Offering Date and Settlement Date, that:
(a) The Registration Statement (i) has been prepared by the Fund in conformity with the requirements of the Securities Act and the Investment Company Act in all material respects; (ii) has been filed with the U.S. Securities and Exchange Commission (the Commission) under the Securities Act and the Investment Company Act; and (iii) heretofore became, and is, effective; the Registration Statement sets forth the terms of the offering, sale and plan of distribution of the Shares and contains additional information concerning the Fund and its business; no stop order of the Commission preventing or suspending the use of the Basic Prospectus (as defined herein), the Prospectus Supplement (as defined herein) or the Prospectus (as defined herein), or the effectiveness of the Registration Statement, has been issued, and no proceedings for such purpose have been instituted or, to the Funds knowledge, have been threatened by the Commission. Except where the context otherwise requires, Registration Statement, as used herein, means, collectively, the various parts of the registration statement, as amended at the time of effectiveness for purposes of Section 11 of the Securities Act (the Effective Time), as such section applies to the Distributor, including (1) all documents filed as a part thereof or incorporated or deemed to be incorporated by reference therein, and (2) any information contained or incorporated by reference in a prospectus filed with the Commission pursuant to Rule 424 under the Securities Act, to the extent such information is deemed to be part of the registration statement at the Effective Time. Basic Prospectus, as used herein, means the final prospectus filed as part of the Registration Statement, including the related statement of additional information, together with any amendments or supplements thereto as of the date of this Agreement. Except where the context otherwise requires, Prospectus Supplement, as used herein, means the final prospectus supplement, including the related statement of additional information, relating to the Shares, filed by the Fund with the Commission pursuant to Rule 424 under the Securities Act, in the form furnished by the Fund to the Distributor in connection with the offering of the Shares. Except where the context otherwise requires, Prospectus, as used herein, means the Prospectus Supplement together with the Basic Prospectus attached to or used with the Prospectus Supplement. Any reference herein to the registration statement, the Registration Statement, the Basic Prospectus, the Prospectus Supplement or the Prospectus shall be deemed to refer to and include the documents, if any, incorporated by reference, or deemed to be incorporated by reference, therein.
3
(b) The Fund is duly registered under the Investment Company Act as a closed-end management investment company. A notification of registration of the Fund as an investment company under the Investment Company Act on Form N-8A (the Investment Company Act Notification) has been prepared by the Fund in conformity with the Investment Company Act and has been filed with the Commission and, at the time of filing thereof and at the time of filing any amendment or supplement thereto, conformed in all material respects with all applicable provisions of the Investment Company Act. The Fund has not received any notice in writing from the Commission pursuant to Section 8(e) of the Investment Company Act with respect to the Investment Company Act Notification or the Registration Statement (or any amendment or supplement to either of them). No person is serving or acting as an officer, Director (as defined below) or investment adviser of the Fund except in accordance with the provisions of the Investment Company Act, provided that for purposes of the foregoing representation with respect to officers and the Board of Directors of the Fund (each a Director, and together the Board), the Fund shall be entitled to rely on representations from such officers and Directors.
(c) The Registration Statement, the Investment Company Act Notification and the Prospectus, as from time to time amended or supplemented, each complied when it became effective or was filed (as the case may be), complies as of the date hereof and, as amended or supplemented, will comply, at each time of purchase of Shares in connection with the ATM offerings, and at all times during which a prospectus is required by the Securities Act to be delivered in connection with any sale of Shares, in all material respects, with the requirements of the Securities Act and the Investment Company Act; the Registration Statement did not, as of the Effective Time, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; at no time during the period that begins on the earlier of the date of the Basic Prospectus and the date the Basic Prospectus was filed with the Commission and ends at the later of the time of purchase of Shares in connection with the ATM offerings, and the end of the period during which a prospectus is required by the Securities Act to be delivered in connection with any sale of Shares did or will the Prospectus, as from time to time amended or supplemented, include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the Fund does not make any representation or warranty with respect to any statement contained in the Registration Statement, the Basic Prospectus or the Prospectus in reliance upon and in conformity with information furnished in writing by the Distributor or any sub-placement agents, or on the Distributors or any sub-placement agents behalf, to the Fund expressly for use in the Registration Statement or the Prospectus (the Agent Provided Information).
(d) The financial statements incorporated by reference in the Registration Statement or the Prospectus, together with the related notes and schedules, present fairly in all material respects the financial position of the Fund as of the dates indicated and the results of operations, cash flows and changes in shareholders equity of the Fund for the periods specified and have been prepared in compliance in all material respects with the requirements of the Securities Act, the Investment Company Act and the Exchange Act, and in conformity in all material respects with U.S. generally accepted accounting principles applied on a consistent basis during the periods involved; the other financial and statistical data contained or incorporated by reference in the Registration Statement or the Prospectus are accurately and fairly presented, in all material respects, and prepared on a basis consistent with the
4
financial statements and books and records of the Fund in all material respects; there are no financial statements that are required to be included or incorporated by reference in the Registration Statement, the Basic Prospectus or the Prospectus by the Securities Act, the Investment Company Act or the Exchange Act that are not included or incorporated by reference as required; and the Fund does not have any material liabilities or obligations, direct or contingent (including any off-balance sheet obligations), not described in the Registration Statement (excluding the exhibits thereto).
(e) As of the date of this Agreement, the Fund has an authorized and outstanding capitalization as set forth in the Registration Statement, the Basic Prospectus and the Prospectus and, with respect to any issuance and sale under this Agreement, the Fund shall have as of the date of the most recent amendment or supplement to the Registration Statement or Prospectus, an authorized and outstanding capitalization as set forth in the Registration Statement and the Prospectus; all of the issued and outstanding Common Shares have been duly authorized and validly issued and are fully paid and non-assessable, have been issued in material compliance with all applicable securities laws and were not issued in violation of any preemptive right, resale right, right of first refusal or similar right.
(f) The Fund has been duly formed, has legal existence as a corporation and is in good standing under the laws of Maryland, with full power and authority to own, lease and operate and conduct its business as described in the Registration Statement, the Basic Prospectus and the Prospectus and to issue, sell and deliver the Shares as contemplated herein. The Fund is duly qualified to do business as a foreign entity and is in good standing in each jurisdiction where the conduct of its business requires such qualification, except where the failure to be so qualified and in good standing would not, individually or in the aggregate, have a material adverse effect on the business, properties, financial condition or results of operations of the Fund.
(g) The Shares have been duly and validly authorized and, when issued and delivered against payment therefor as provided herein, will be duly and validly issued, fully paid and non-assessable and free of statutory and contractual preemptive rights, resale rights, rights of first refusal and similar rights; the Shares, when issued and delivered against payment therefor as provided herein, will be free of any restriction upon the voting or transfer thereof pursuant to the Funds Articles of Incorporation, as amended or supplemented, Amended and Restated Bylaws, as further amended or supplemented, or any agreement or other instrument to which the Fund is a party. The Common Shares, including the Shares, conform in all material respects to the description thereof, if any, contained or incorporated by reference in the Registration Statement, the Basic Prospectus or the Prospectus; and the certificates for the Shares, if any, are in due and proper form.
(h) The Fund is in material compliance with the rules of the New York Stock Exchange (the Stock Exchange), including, without limitation, the requirements for continued listing of the Shares on the Stock Exchange and the Fund has not received any written notice from the Stock Exchange regarding the delisting of the Shares from the Stock Exchange. The Shares will be duly listed, and admitted and authorized for trading, subject to official notice of issuance, on the Stock Exchange.
5
(i) No approval, authorization, consent or order of or filing with any federal, state, local or foreign governmental or regulatory commission, board, body, authority or agency, or of or with any self-regulatory organization or other non-governmental regulatory authority (including, without limitation, the Stock Exchange), or approval of the shareholders of the Fund that has not already been obtained, is required in connection with the issuance and sale of the Shares or the consummation by the Fund of the transactions contemplated hereby, other than (i) the registration of the Shares under the Securities Act, which has been effected, (ii) the listing of the Shares with the Stock Exchange, upon official notice of issuance, (iii) any necessary qualification under the securities or blue sky laws of the various jurisdictions in which the Shares are being offered by the Fund or (iv) any necessary qualification pursuant to the rules of FINRA.
Section 3. Duties of the Fund.
(a) The Fund shall take, from time to time, but subject always to any necessary approval of the Board or of its shareholders, all necessary action to fix the number of authorized Common Shares, to the end that the Fund will have a number of authorized but unissued Common Shares at least equal to the number of Common Shares available for sale pursuant to this Agreement.
(b) For purposes of the ATM offering of Shares, the Fund will furnish to the Distributor and any sub-placement agents copies of its most recent amendment to its Registration Statement, its most recent Prospectus and all amendments and supplements thereto, and other documentation the Distributor may reasonably request for use in the ATM offering of Shares. The Distributor and the sub-placement agents are authorized to furnish to prospective investors only such information concerning the Fund and the ATM offering as may be contained in the Registration Statement, the Prospectus, the Funds publicly available formation documents, or any other documents (including sales material), that are expressly approved by the Fund for such purpose.
(c) The Fund shall furnish to the Distributor copies of all financial statements of the Fund which the Distributor may reasonably request for use in connection with its duties hereunder, and this shall include, upon request by the Distributor, one certified copy of all financial statements prepared for the Fund by independent public accountants.
(d) The Fund shall use its best efforts to qualify and maintain, to the extent required by applicable law, the qualification of Shares for sale under the securities laws of such jurisdictions as the Distributor and the Fund may approve, provided that the Fund shall not be required in connection therewith to qualify as a foreign corporation or dealer in securities or to file a general consent to service of process in any jurisdiction or meet any other requirement in connection with this Section 3(d) deemed by the Fund to be unduly burdensome. Any such qualification may be withheld, terminated or withdrawn by the Fund at any time in its discretion. The expense of qualification and maintenance of qualification shall be borne by the Fund. The Distributor shall furnish such information and other material relating to its affairs and activities as may be required by the Fund in connection with such qualification.
6
(e) The Fund will furnish, in reasonable quantities upon request by the Distributor, copies of its annual and semi-annual reports.
(f) The Fund will furnish the Distributor with such other documents as it may reasonably require, from time to time, for the purpose of enabling it to perform its duties as contemplated by this Agreement.
Section 4. Duties of the Distributor.
(a) The Distributor shall use its best efforts to perform its duties hereunder. The services of the Distributor to the Fund hereunder are not to be deemed exclusive and nothing herein contained shall prevent the Distributor from entering into like arrangements with other investment companies so long as the performance of its obligations with respect to the Fund hereunder is not impaired thereby.
(b) In performing its duties hereunder, the Distributor shall comply with the requirements of all applicable laws relating to the sale of securities in all material respects. Neither the Distributor nor any sub-placement agent having an agreement to offer and sell Shares pursuant to Section 5 hereof nor any other person is authorized by the Fund to give any information or to make any representations, other than those contained in its Registration Statement, Prospectus and any sales literature specifically approved for such use by the Fund.
(c) The Distributor shall review and file with FINRA as applicable, all sales literature (advertisements, brochures and shareholder communications) prepared in connection with the ATM offerings for the Fund.
(d) The Distributor agrees to supply the following additional services, either on its own or in conjunction with the Funds other service providers, including but not limited to the Funds investment adviser, together with such other services as set forth throughout this Agreement:
1. | handling inquiries from sub-placement agents regarding the Fund; |
2. | assisting in the enhancement of communications between sub-placement agents and the Fund; |
3. | communicating the Minimum Price or Minimum Sales Price to any sub-placement agents and instructing any sub-placement agents not to sell Shares if such sales cannot be effected at or above the Minimum Price or the Minimum Sales Price; |
4. | communicating the maximum amount of Shares to be sold on any Offering Date to any sub-placement agents; |
5. | notifying any sub-placement agents of any suspension or termination of the ATM offering of Shares, together with any corresponding resumption of the ATM offering of Shares; |
7
6. | coordinating delivery of any Shares sold through sub-placement agents to such sub-placement agents on the Settlement Date against payment of the gross sales proceeds for the sale of such Shares, less any applicable sub-placement agent selling commission; |
7. | delivering the Funds Prospectus to any sub-placement agents; |
8. | identifying potential sub-placement agents; |
9. | monitoring the performance of sub-placement agents; |
10. | providing any necessary reconciliation, accounting and recordkeeping services in respect of the ATM offerings of Shares, including with respect to the underwriting compensation paid by the Fund to the Distributor in respect thereof; and |
11. | providing such other information, assistance and services as may be reasonably requested by the Fund. |
For the avoidance of doubt, the Distributor shall not sell any shares of the Fund directly to any investors.
(e) The Distributor shall report to the Board at least quarterly, or more frequently, as requested by the Board, regarding: (i) the nature of the services provided by the Distributor hereunder; (ii) the amount of compensation sub-placement agents, if any, are entitled to retain or be paid by the Distributor; and (iii) the aggregate amount of underwriting compensation paid by the Fund to the Distributor in respect of the ATM offerings of Shares.
(f) The Distributor represents and warrants to the Fund that it has all necessary licenses to perform the services contemplated hereunder and will perform such services in compliance with all applicable rules and regulations.
Section 5. Agreements with Sub-Placement Agents.
(a) The Distributor may enter into Sub-Placement Agent Agreements, on such terms and conditions as the Distributor determines are not inconsistent with this Agreement, with sub-placement agents to act as the Distributors agents to effect the sale of the Shares in the ATM offerings. Such sub-placement agents shall sell Shares only at market prices subject to the Minimum Price and the Minimum Sales Price. This Agreement shall not be construed as authorizing any dealer or other person to accept orders for sale on the Funds behalf or to otherwise act as the Funds agent for any purpose. The Distributor shall not be responsible for the acts of other dealers or agents except as and to the extent that they shall be acting for the Distributor or under the Distributors direction or authority.
(b) The Distributor shall offer and sell Shares only through such sub-placement agents who are acting as brokers or dealers who are registered as broker-dealers under the provisions of the Exchange Act and members in good standing of FINRA and who agree to abide by the rules of FINRA.
8
(c) The Distributor shall obtain assurance, reasonably satisfactory to the Fund, from any sub-placement agents which it engages of the compliance by such sub-placement agents with the terms of this Agreement, applicable federal and state securities laws and the rules of FINRA.
Section 6. Sales Commission; Compensation.
(a) The Fund shall pay the Distributor an amount equal to 1.00% of the gross sales price per Share of the Shares sold.
(b) The Distributor shall pay to the sub-placement agents the sub-placement agent commissions agreed to between the Distributor and such sub-placement agents, or may authorize such sub-placement agents to retain such sub-placement agent commissions from the gross sales proceeds from the sale of such Shares, which shall be payable from the commissions payable to the Distributor under Section 6(a) hereof.
(c) The Fund hereby represents and warrants to the Distributor that (i) the terms of this Agreement, (ii) the fees and expenses associated with this Agreement, and (iii) any benefits accruing to the Distributor or to the Funds investment adviser or sponsor or another affiliate of the Fund in connection with this Agreement, which the Fund has agreed to pay, including but not limited to any fee waivers, conversion cost reimbursements, up-front payments, signing payments or periodic payments relating to this Agreement have been fully disclosed to the Board and that, if required by applicable law, the Board has approved or will approve the terms of this Agreement, any such fees and expenses, and any such benefits.
Section 7. Payment of Expenses.
(a) The Fund shall bear all of its own costs and expenses, including fees and disbursements of its counsel and auditors, in connection with the preparation of its Prospectus, Statement of Additional Information, if any, the preparation and filing of any required registration statements under the Securities Act and/or the Investment Company Act, and all amendments and supplements thereto, and in connection with any fees and expenses incurred with respect to any filing requirements of FINRA and preparing and mailing annual and interim reports and proxy materials to shareholders (including but not limited to the expense of setting in type any such Registration Statement, Prospectus, interim reports or proxy materials).
(b) The Fund shall bear any cost and expenses of qualification of the Shares for sale pursuant to this Agreement.
(c) The Distributor shall bear all expenses incurred by it in connection with its duties and activities under this Agreement, including the compensation of sub-placement agents for sales of the Funds Shares, provided that it shall pay such sub-placement agents only for so long as and to the extent that it receives such compensation from the Fund, and fees and expenses of Distributors counsel (except for any FINRA filing fees or blue sky fees paid on behalf of the Fund or the Distributor by such counsel).
9
Section 8. Limitation of Liability; Indemnification.
(a) The Distributor shall not be liable for any error of judgment or mistake of law or for any loss suffered by the Fund in connection with the matters to which this Agreement relates, except a loss resulting from willful misfeasance, bad faith or gross negligence on its part in the performance of its duties or from reckless disregard by it of its obligations and duties under this Agreement. The Distributor shall not be liable for any damages arising out of any action or omission to act by any prior service provider of the Fund or for any failure to discover any such error or omission (provided that this sentence shall not apply where the Distributor was the prior service provider). Notwithstanding anything in this Agreement to the contrary, the Distributor shall not be liable for damages occurring directly or indirectly by reason of circumstances beyond its reasonable control.
(b) The Fund agrees that it will indemnify, defend and hold harmless the Distributor, its several officers, and directors, and any person who controls the Distributor within the meaning of Section 15 of the Securities Act, from and against any losses, claims, damages or liabilities, joint or several, to which the Distributor, its several officers, and directors, and any person who controls the Distributor within the meaning of Section 15 of the Securities Act, may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions or proceedings in respect thereof) (i) arise out of, or are based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, the Prospectuses or in any application or other document executed by or on behalf of the Fund or are based upon information furnished by or on behalf of the Fund filed in any state in order to qualify the Shares under the securities or blue sky laws thereof (Blue Sky Application) or arise out of, or are based upon, the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading; or (ii) arise out of, or are based upon, any breach of the representations, warranties or covenants of the Fund contained in this Agreement; provided, however, that the Fund shall not be liable in any case to the extent that such loss, claim, damage or liability arises out of, or is based upon, any untrue statement, alleged untrue statement, or omission or alleged omission made in the Registration Statement, the Prospectus or any Blue Sky Application with respect to the Fund in reliance upon and in conformity with any information furnished in writing by the Distributor, or on the Distributors behalf, to the Fund expressly for use in the Registration Statement or the Prospectus, or arising out of the failure of the Distributor to deliver a current Prospectus.
(c) The Distributor will indemnify and hold harmless the Fund and its several officers and Directors, and any person who controls the Fund within the meaning of Section 15 of the Securities Act, from and against any losses, claims, damages or liabilities, joint or several, to which any of them may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions or proceedings in respect thereof) arise out of, or are based upon, any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, the Prospectus or any Blue Sky Application, or arise out of, or are based upon, the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, which statement or omission was made in reliance upon and in conformity with information furnished in writing to the Fund or any of its several officers by or on behalf of the Distributor specifically for inclusion therein, and will reimburse the Fund and its several officers, Directors and such controlling persons for any legal or other expenses reasonably incurred by any of them in investigating, defending or preparing to defend any such action, proceeding or claim.
10
(d) At the request and direction of the Fund, the Distributor enters into Sub-Placement Agent Agreements. The Distributor will not be obligated to make payments to any such Sub-Placement Agent unless the Distributor has received an authorized payment from the Fund. In addition, to the extent that the Distributor is requested or required by the Fund to enter into Sub-Placement Agent Agreements, the Distributor and each of its affiliates, members, shareholders, directors, officers, partners, employees, agents, successors or assigns (Distributor Associates) shall not be liable to the Fund for any action or inaction of any Distributor Associate except to the extent of direct Losses1 finally determined by a court of competent jurisdiction to have resulted solely from the gross negligence, willful misconduct or fraud of the Distributor in the performance of the Distributors duties, obligations, representations, warranties or indemnities under a Sub-Placement Agent Agreement. Under no circumstances shall Distributor Associates be liable for Losses that are indirect, special, incidental, consequential, punitive, exemplary or enhanced or that represent lost profits, opportunity costs or diminution of value. The Fund shall indemnify, defend and hold harmless Distributor Associates from and against Losses (including legal fees and costs to enforce this provision) that Distributor Associates suffer, incur, or pay as a result of any third-party claim or claim among the parties arising out of the subject matter of or otherwise in any way related to a Sub-Placement Agent Agreement (Claims). Any expenses (including legal fees and costs) incurred by Distributor Associates in defending or responding to any Claims (or in enforcing this provision) shall be paid by the Fund on a quarterly basis prior to the final disposition of such matter upon receipt by the Fund of an undertaking by the Distributor to repay such amount if it shall be determined that a Distributor Associate is not entitled to be indemnified. Notwithstanding the foregoing, nothing contained in this paragraph or elsewhere in this Agreement shall constitute a waiver by the Fund of any of its legal rights available under U.S. federal securities laws or any other laws whose applicability is not permitted to be contractually waived.
(e) An indemnified person under this Section 8 (the Indemnified Party) shall give written notice to the other party (the Indemnifying Party) of any loss, damage, expense, liability or claim in respect of which the Indemnifying Party has a duty to indemnify such Indemnified Party under Section 8(b) or (c) hereof (a Claim), specifying in reasonable detail the nature of the loss, damage, expense, liability or claim for which indemnification is sought, except that any delay or failure so to notify such Indemnifying Party shall only relieve such Indemnifying Party of its obligations hereunder to the extent, if at all, that such Indemnifying Party is actually prejudiced by reason of such delay or failure.
1 | As used in this paragraph, the term Losses means any and all compensatory, direct, indirect, special, incidental, consequential, punitive, exemplary, enhanced or other damages, settlement payments, attorneys fees, costs, damages, charges, expenses, interest, applicable taxes or other losses of any kind. |
11
(f) If a Claim results from any action, suit or proceeding brought or asserted against an Indemnified Party, the Indemnifying Party shall assume the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses. The Indemnified Party shall have the right to employ separate counsel in such action, suit or proceeding and participate in such defense thereof, but the fees and expenses of such separate counsel shall be at the expense of the Indemnified Party unless (i) the Indemnifying Party has agreed in writing to pay such fees and expenses, (ii) the Indemnifying Party has failed within a reasonable time to assume the defense and employ counsel or (iii) the named parties to any such action, suit or proceeding (including any impleaded parties) include both such Indemnified Party and Indemnifying Party and such Indemnified Party shall have been advised by its counsel that representation of such Indemnified Party and Indemnifying Party by the same counsel would be inappropriate under applicable standards of professional conduct (whether or not such representation by the same counsel has been proposed) due to actual or potential differing interests between the Indemnifying Party and the Indemnified Party (in which case the Indemnifying Party shall not have the right to assume the defense of such action, suit or proceeding on behalf of such Indemnified Party). It is understood, however, that the Indemnifying Party shall, in connection with any one action, suit or proceeding or separate but substantially similar or related actions, suits or proceedings in the same jurisdiction arising out of the same general allegations or circumstances be liable for the reasonable fees and expenses of only one separate firm of attorneys (in addition to any local counsel) at any time for all such Indemnified Parties not having actual or potential differing interests with the Indemnifying Party or among themselves, which firm shall be designated in writing by an authorized representative of such parties and that all such fees and expenses shall be reimbursed promptly as they are incurred. The Indemnifying Party shall not be liable for any settlement of any such action, suit or proceeding effected without its written consent, but if settled with such written consent or if there be a final judgment for the plaintiff in any such action, suit or proceeding, the Indemnifying Party agrees to indemnify and hold harmless any Indemnified Party from and against any loss, liability, damage or expense by reason by such settlement or judgment.
(g) With respect to any Claim not within Section 8(e) hereof, the Indemnifying Party shall have twenty (20) days from receipt of notice from the Indemnified Party of such Claim within which to respond thereto. If the Indemnifying Party does not respond within such twenty-day period, it shall be deemed to have accepted responsibility to make payment and shall have no further right to contest the validity of such Claim. If the Indemnifying Party notifies the Indemnified Party within such twenty-day period that it rejects such Claim in whole or in part, the Indemnified Party shall be free to pursue such remedies as may be available to the Indemnified Party under applicable law.
(h) If the indemnification provided for in this Section 8 is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party harmless in respect of any losses, damages, expenses, liabilities or claims referred to therein, then each applicable Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party as a result of such losses, damages, expenses, liabilities or claims in such proportion as is appropriate to reflect (i) the relative benefits received by the Indemnified Party, on the one hand, and the Indemnifying Party, on the other hand, from the offering of the Shares; or (ii) if, but only if, the allocation provided for in clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause
12
(i) but also the relative fault of the Indemnified Party, on the one hand, and of the Indemnifying Party, on the other, in connection with any statements or omissions or other matters which resulted in such losses, damages, expenses, liabilities or claims, as well as any other relevant equitable considerations. The relative fault of the parties hereto shall be determined by reference to, among other things, whether the untrue statement or alleged untrue statement of a material fact or omission or alleged omission relates to information supplied by such party, on one hand, or by the other party, on the other hand, and the parties relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The amount paid or payable by a party hereto as a result of the losses, damages, expenses, liabilities and claims referred to in this subsection shall be deemed to include any legal or other fees or expenses reasonably incurred by such party in connection with investigating, preparing to defend or defending any proceeding. The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 8 were determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in this Section 8(g). No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.
(i) Notwithstanding any other provisions in this Section 8, no party shall be entitled to indemnification or contribution under this Agreement against any loss, claim, liability, expense or damage arising by reason of such persons willful misfeasance, bad faith or gross negligence in the performance of its duties hereunder or by reason of such persons reckless disregard of such persons obligations and duties thereunder.
(j) The indemnity and contribution agreements contained in this Section 8 and the covenants, warranties and representations of the parties contained in this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the Fund, its, Directors or officers or any person (including each officer or Director of such person) who controls the Fund within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, or by or on behalf of the Distributor, its directors or officers or any person who controls the Distributor within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, and shall survive any termination of this Agreement or the issuance and delivery of the Shares.
(k) IN NO EVENT WILL ANY PARTY TO THIS AGREEMENT BE LIABLE TO ANY OTHER PERSON OR ANY THIRD PARTY FOR ANY CONSEQUENTIAL, INCIDENTAL, SPECIAL OR INDIRECT DAMAGES (INCLUDING BUT NOT LIMITED TO LOST PROFITS), EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES.
Section 9. Duration and Termination of this Agreement.
(a) This Agreement may be terminated at any time, without the payment of any penalty, by the Fund or by the Distributor, on sixty days written notice to the other party.
13
(b) Unless earlier terminated pursuant to Section 9(a) hereof, this Agreement shall automatically terminate upon the issuance and sale of all of the Shares through the Distributor or any sub-placement agents on the terms and subject to the conditions set forth herein.
(c) This Agreement shall remain in full force and effect unless terminated pursuant to Sections 9(a) or 9(b) hereof.
(d) Any termination of this Agreement shall be effective on the date specified in such notice of termination; provided that such termination shall not be effective until the close of business on the date of receipt of such notice by the other party. If such termination shall occur prior to the Settlement Date for any sale of Shares, such Shares shall settle in accordance with the provisions of this Agreement.
Section 10. Amendments of this Agreement. This Agreement may be amended by the parties only pursuant to a written instrument executed by the Fund and the Distributor.
Section 11. Governing Law. This Agreement and any claim, counterclaim or dispute of any kind or nature whatsoever arising out of or in any way relating to this Agreement, directly or indirectly, shall be governed by, and construed in accordance with, the internal laws of the State of New York. To the extent that the applicable law of the State of New York, or any of the provisions herein, conflict with the applicable provisions of the Investment Company Act, the latter shall control.
Section 12. Waiver of Jury Trial. EACH OF THE FUND (ON ITS BEHALF AND, TO THE EXTENT PERMITTED BY APPLICABLE LAW, ON BEHALF OF ITS AFFILIATES) AND THE DISTRIBUTOR (ON ITS BEHALF AND, TO THE EXTENT PERMITTED BY APPLICABLE LAW, ON BEHALF OF ITS MEMBERS AND AFFILIATES) WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED UPON CONTRACT, TORT OR OTHERWISE) IN ANY WAY ARISING OUT OF OR RELATING TO THIS AGREEMENT.
Section 13. Miscellaneous.
(a) The captions in this Agreement are included for convenience of reference only and in no way define or delimit any of the provisions hereof or otherwise affect their construction or effect.
(b) This Agreement constitutes the entire agreement and supersedes all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof. If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of this Agreement shall not be affected thereby.
(c) This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns and the officers, and directors, and controlling persons referred to in Section 8 hereof. Neither party may assign its rights or obligations under this Agreement without the prior written consent of the other party.
14
(d) The parties acknowledge and agree that all share related numbers contained in this Agreement shall be adjusted to take into account any stock split, stock dividend or similar event effected with respect to the Shares.
(e) The terms affiliated person and interested person, when used in this Agreement, shall have the respective meanings specified in the Investment Company Act.
Section 14. Proprietary and Confidential Information. The Distributor agrees on behalf of itself and its employees to treat confidentially and as proprietary information of the Fund all records and other information relative to the Fund and prior, present or potential shareholders, and not to use such records and information for any purpose other than performance of its responsibilities and duties hereunder, except after prior notification to and approval in writing by the Fund, which approval shall not be unreasonably withheld and shall not be required where the Distributor may be exposed to civil or criminal contempt proceedings for failure to comply, when requested to divulge such information by duly constituted authorities, or when so requested by the Fund. The provisions of this Section 14 shall survive termination of this Agreement.
Notwithstanding anything in this Agreement to the contrary, each party hereto agrees that: (i) any Nonpublic Personal Information, as defined under Section 248.3(t) of Regulation S-P (Regulation S-P), promulgated under the Gramm-Leach-Bliley Act (the Act), disclosed by a party hereunder is for the specific purpose of permitting the other party to perform the services set forth in this Agreement, and (ii) with respect to such information, each party will comply with Regulation S-P and the Act and will not disclose any Nonpublic Personal Information received in connection with this Agreement to any other party, except to the extent as necessary to carry out the services set forth in this Agreement or as otherwise permitted by Regulation S-P or the Act.
Section 15. Notices. All communications hereunder will be in writing and effective only on receipt, and will be mailed, delivered or emailed and confirmed to:
If to the Distributor:
ALPS Distributors, Inc.
1290 Broadway, Suite 1000
Denver, Colorado 80203
Attention: Stephen Kyllo
Email: stephen.kyllo@sscinc.com
If to the Fund:
Columbia Seligman Premium Technology Growth Fund, Inc.
c/o Columbia Management Investment Advisers, LLC
485 Lexington Avenue, 12th Floor
New York, NY 10017
Attention: Joseph DAlessandro
15
Email: joseph.l.dalessandro@ampf.com
Attention: Marc Zeitoun
Email: Marc.Zeitoun@columbiathreadneedle.com
[The remainder of this page is intentionally left blank]
16
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written. This Agreement may be executed by the parties hereto in any number of counterparts, all of which shall constitute one and the same instrument.
COLUMBIA SELIGMAN PREMIUM TECHNOLOGY GROWTH FUND, INC. | ||
By: | /s/ Daniel J. Beckman | |
Name: Daniel J. Beckman | ||
Title: President | ||
ALPS DISTRIBUTORS, INC. | ||
By: | /s/ Stephen Kyllo | |
Name: Stephen Kyllo | ||
Title: SVP & Director |
![]() |
ROPES & GRAY LLP PRUDENTIAL TOWER 800 BOYLSTON STREET BOSTON, MA 02199-3600 WWW.ROPESGRAY.COM |
June 25, 2024
Columbia Seligman Premium Technology Growth Fund, Inc.
290 Congress Street
Boston, Massachusetts 02210
Ladies and Gentlemen:
We have acted as counsel to Columbia Seligman Premium Technology Growth Fund, Inc. (the Fund) in connection with the Registration Statement of the Fund on Form N-2 (File No. [ ]) under the Securities Act of 1933 and the Investment Company Act of 1940 (File No. 811-22328) (the Registration Statement) as amended, with respect to certain of its common shares of beneficial interest (the Common Shares). The Common Shares are to be sold pursuant to a Distribution Agreement substantially in the form filed as an exhibit to the Registration Statement (the Distribution Agreement) between the Fund and ALPS Distributors, Inc.
We have examined the Funds Articles of Incorporation, as amended, on file with the Maryland State Department of Assessments & Taxation, and the Funds Bylaws, and are familiar with the actions taken by the Fund in connection with the issuance and sale of the Common Shares. We have also examined such other documents and records as we have deemed necessary for the purposes of this opinion. In rendering the opinions expressed herein, we have relied solely on the opinion, dated as of July 21, 2024, of Venable LLP insofar as such opinion relates to the laws of the State of Maryland (subject to all of the assumptions and qualifications to which such opinion is subject), and we have made no independent examination of the laws of that jurisdiction. We are providing a copy of that opinion together with this opinion, which is subject to the same limitations and assumptions as those set forth in the opinion of Venable LLP.
The opinions expressed herein are limited to matters governed by the laws of the State of Maryland and the federal laws of the United States of America.
-2- | June 25, 2024 |
Based upon the foregoing, we are of the opinion that:
1. | The Fund is a duly organized and validly existing unincorporated association under and by virtue of the laws of the State of Maryland. |
2. | The Common Shares have been duly authorized and, when issued and paid for in accordance with the Distribution Agreement, will be validly issued, fully paid and, except as described in the following paragraph, nonassessable by the Fund. |
We understand that this opinion is to be used in connection with the registration of the Common Shares for offering and sale pursuant to the Securities Act of 1933, as amended. We consent to the filing of this opinion with and as part of the Registration Statement on Form N-2 related to such offering and sale.
Very truly yours, |
Ropes & Gray LLP |
![]() |
750 E. PRATT STREET SUITE 900 BALTIMORE, MD 21202 T 410.244.7400 F 410.244.7742 www.Venable.com | |
June 21, 2024
Columbia Seligman Premium Technology Growth Fund, Inc.
290 Congress Street
Boston, Massachusetts 02210
Re: | Registration Statement on Form N-2 |
1940 Act File No.: 811-22328
Ladies and Gentlemen:
We have served as Maryland counsel to Columbia Seligman Premium Technology Growth Fund, Inc., a Maryland corporation registered under the Investment Company Act of 1940, as amended (the 1940 Act), as a closed-end management investment company (the Company), in connection with certain matters of Maryland law arising out of the offering and sale of up to 8,000,000 shares (the Shares) of common stock, $0.01 par value per share (the Common Stock), of the Company, covered by the above-referenced Registration Statement, and all amendments thereto (the Registration Statement), filed by the Company with the United States Securities and Exchange Commission (the Commission) under the Securities Act of 1933, as amended (the 1933 Act), and the 1940 Act. The Shares are to be issued from time to time in public offerings at negotiated prices pursuant to a Prospectus, in substantially the form to be filed by the Company with the Commission (the Prospectus).
In connection with our representation of the Company, and as a basis for the opinion hereinafter set forth, we have examined originals, or copies certified or otherwise identified to our satisfaction, of the following documents (collectively, the Documents):
1. The Registration Statement;
2. The Prospectus, including the related statement of additional information;
3. The Distribution Agreement, dated as of June 20, 2024 (the Distribution Agreement), by and between the Company and ALPS Distributors, Inc;
3. The charter of the Company (the Charter), certified by the State Department of Assessments and Taxation of Maryland (the SDAT);
4. The Bylaws of the Company, as amended, certified as of the date hereof by an officer of the Company;
5. A certificate of the SDAT as to the good standing of the Company, dated as of a recent date;
Columbia Seligman Premium Technology Growth Fund, Inc.
June 21, 2024
Page 2
6. Resolutions (the Resolutions) adopted by the Board of Directors of the Company (the Board of Directors) relating to, among other matters, the registration and issuance of the Shares and the execution, delivery and performance by the Company of the Distribution Agreement, certified as of the date hereof by an officer of the Company;
7. A certificate executed by an officer of the Company, dated as of the date hereof; and
8. Such other documents and matters as we have deemed necessary or appropriate to express the opinion set forth below, subject to the assumptions, limitations and qualifications stated herein.
In expressing the opinion set forth below, we have assumed the following:
1. Each individual executing any of the Documents, whether on behalf of such individual or another person, is legally competent to do so.
2. Each individual executing any of the Documents on behalf of a party (other than the Company) is duly authorized to do so.
3. Each of the parties (other than the Company) executing any of the Documents has duly and validly executed and delivered each of the Documents to which such party is a signatory, and such partys obligations set forth therein are legal, valid and binding and are enforceable in accordance with all stated terms.
4. All Documents submitted to us as originals are authentic. The form and content of all Documents submitted to us as unexecuted drafts do not differ in any respect relevant to this opinion from the form and content of such Documents as executed and delivered. All Documents submitted to us as certified or photostatic copies conform to the original documents. All signatures on all such Documents are genuine. All public records reviewed or relied upon by us or on our behalf are true and complete. All representations, warranties, statements and information contained in the Documents are true and complete. There has been no oral or written modification of or amendment to any of the Documents, and there has been no waiver of any provision of any of the Documents, by action or omission of the parties or otherwise.
5. Upon any issuance of the Shares, the total number of shares of Common Stock issued and outstanding will not exceed the total number of shares of Common Stock that the Company is then authorized to issue under the Charter.
Based upon the foregoing, and subject to the assumptions, limitations and qualifications stated herein, it is our opinion that:
Columbia Seligman Premium Technology Growth Fund, Inc.
June 21, 2024
Page 3
1. The Company is a corporation duly incorporated and existing under and by virtue of the laws of the State of Maryland and is in good standing with the SDAT.
2. The issuance of the Shares has been duly authorized and, when and if issued and delivered by the Company pursuant to the Distribution Agreement, the Resolutions and the Registration Statement against payment of the consideration set forth therein, the Shares will be validly issued, fully paid and nonassessable.
The foregoing opinion is limited to the laws of the State of Maryland and we do not express any opinion herein concerning federal law or any other state law. We express no opinion as to the applicability or effect of the 1940 Act or other federal securities laws, or state securities laws, including the securities laws of the State of Maryland, or as to federal or state laws regarding fraudulent transfers.
The opinion expressed herein is limited to the matters specifically set forth herein and no other opinion shall be inferred beyond the matters expressly stated. We assume no obligation to supplement this opinion if any applicable law changes after the date hereof or if we become aware of any fact that might change the opinion expressed herein after the date hereof.
This opinion is being furnished to you for submission to the Commission as an exhibit to the Registration Statement. We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the use of the name of our firm therein. In giving this consent, we do not admit that we are within the category of persons whose consent is required by Section 7 of the 1933 Act.
Very truly yours, |
/s/ Venable LLP |
116827-586329
Exhibit (n)
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form N-2 of Columbia Seligman Premium Technology Growth Fund, Inc. of our report dated February 22, 2024, relating to the financial statements and financial highlights, which appears in Columbia Seligman Premium Technology Growth Fund, Inc.s Annual Report on Form N-CSR for the year ended December 31, 2023. We also consent to the references to us under the headings Financial Highlights and Investment Performance, Independent Registered Public Accounting Firm, and Legal Opinions and Experts in such Registration Statement.
/s/PricewaterhouseCoopers LLP
Minneapolis, Minnesota
June 25, 2024
Calculation of Filing Fee Tables
Form N-2
(Form Type)
Columbia Seligman Premium Technology Growth Fund, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Table 2: Fee Offset Claims and Sources
(a) | Estimated solely for purposes of calculating the filing fee in accordance with Rule 457(c) under the Securities Act of 1933. |